Category | N=134 | (%) | |
---|---|---|---|
Gender | Male | 112 | 84 |
Female | 22 | 16 | |
Mean age (years, range) | 70 (18–94) | ||
Up to 74 | 90 | 67 | |
75+ | 44 | 33 | |
Acquired MRSA | 89 | 66 | |
Surgical procedure | 54 | ||
Clean | 4 | ||
Clean-contaminated | 32 | ||
Contaminated | 18 | ||
Antibiotics use before diagnosis of MRSA | 66 | ||
Penicillins | 8 | ||
Second-generation cephalosporins | 28 | ||
Third-generation cephalosporins | 10 | ||
Carbapenems | 22 | ||
Fluoroquinolones | 12 | ||
Aminoglycosides | 2 | ||
Others | 2 | ||
Clinically significant MRSA infection | 69 | 51 | |
Type of infection | Surgical site | 23 | |
Genitourinary | 15 | ||
Blood stream | 11 | ||
Gastrointestinal | 11 | ||
Respiratory | 9 | ||
Imported MRSA | 45 | 34 |